photo of

Details

Role Team Leader / Senior Research Fellow
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an investigator on a number of projects in Mongolia. She is also the co-principal investigator on a Coalition for Epidemic Preparedness Innovations (CEPI) funded COVID-19 vaccine booster study. Dr von Mollendorf has an honorary appointment as a Senior Fellow within the University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics.

Dr von Mollendorf is the project manager for a National Health & Medical Research Council Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific (CRE-PDC) which aims to address research gaps related to pneumococcal conjugate vaccine use in the Asia-Pacific region. It also focuses on building research and leadership capacity for early career researchers in the region.

Prior to 2017 she worked in different research areas, including women's health, HIV and pneumococcal research, in South Africa. Her passion and involvement in research has spanned over an 20 year period and has included adults and children, some vulnerable groups and ranged from clinical trials to observational studies. She also has an interest in the impact of environmental pollution on health.
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an...
Dr Claire von Mollendorf is a medical epidemiologist currently working as a senior research fellow in the New Vaccines and Asia-Pacific Research Groups at the Murdoch Children’s Research Unit (MCRI). She has been with MCRI since 2017 and is an investigator on a number of projects in Mongolia. She is also the co-principal investigator on a Coalition for Epidemic Preparedness Innovations (CEPI) funded COVID-19 vaccine booster study. Dr von Mollendorf has an honorary appointment as a Senior Fellow within the University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Department of Paediatrics.

Dr von Mollendorf is the project manager for a National Health & Medical Research Council Centre of Research Excellence for Pneumococcal Disease Control in the Asia-Pacific (CRE-PDC) which aims to address research gaps related to pneumococcal conjugate vaccine use in the Asia-Pacific region. It also focuses on building research and leadership capacity for early career researchers in the region.

Prior to 2017 she worked in different research areas, including women's health, HIV and pneumococcal research, in South Africa. Her passion and involvement in research has spanned over an 20 year period and has included adults and children, some vulnerable groups and ranged from clinical trials to observational studies. She also has an interest in the impact of environmental pollution on health.

Top Publications

  • Do, LAH, Tsedenbal, N, Khishigmunkh, C, Tserendulam, B, Altanbumba, L, Luvsantseren, D, Ulziibayar, M, Suuri, B, Narangerel, D, Tsolmon, B, et al. Impact of pneumococcal conjugate vaccine 13 introduction on severe lower respiratory tract infections associated with respiratory syncytial virus or influenza virus in hospitalized children in Ulaanbaatar, Mongolia.. IJID Reg 11: 100357 2024
    view publication
  • Fagerli, K, Ulziibayar, M, Suuri, B, Luvsantseren, D, Narangerel, D, Batsaikhan, P, Tsolmon, B, de Campo, J, de Campo, M, Dunne, EM, et al. Impact of childhood 13-valent pneumococcal conjugate vaccine introduction on adult pneumonia hospitalisations in Mongolia: a time series analysis.. Lancet Reg Health West Pac 44: 100983 2024
    view publication
  • von Mollendorf, C, Ulziibayar, M, Nguyen, CD, Batsaikhan, P, Suuri, B, Luvsantseren, D, Narangerel, D, de Campo, J, de Campo, M, Tsolmon, B, et al. Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2-59 Months of Age, Mongolia, 2015-2021.. Emerg Infect Dis 30(3) : 490 -498 2024
    view publication
  • Manna, S, Werren, JP, Ortika, BD, Bellich, B, Pell, CL, Nikolaou, E, Gjuroski, I, Lo, S, Hinds, J, Tundev, O, et al. Streptococcus pneumoniae serotype 33G: genetic, serological, and structural analysis of a new capsule type.. Microbiol Spectr 12(1) : e0357923 2024
    view publication
  • Ratu, FT, Ryan, K, Gidi, NW, Vereti, I, Girma, T, Oats, J, Bucens, I, Robinson, A, von Mollendorf, C, Russell, FM. Direct and indirect effects of COVID-19 on perinatal outcomes in low- and middle-income countries. Gates Open Research 4: 108 2024
    view publication

Page 1 of 18